Showing 1,381 - 1,400 results of 5,914 for search '(((salinger OR sslinge) OR (line OR like)) OR ((link OR (espina OR spinl)) OR (pin OR ping)))', query time: 0.20s Refine Results
  1. 1381
  2. 1382
  3. 1383
  4. 1384
  5. 1385
  6. 1386
  7. 1387
  8. 1388

    Personalised video by Seah, Kai Ler

    Published 2018
    Get full text
    Final Year Project (FYP)
  9. 1389
  10. 1390
  11. 1391
  12. 1392

    Use of smartphones to detect diabetic retinopathy : scoping review and meta-analysis of diagnostic test accuracy studies by Tan, Choon Han, Kyaw, Bhone Myint, Smith, Helen, Tan, Colin Siang Hui, Car, Lorainne Tudor

    Published 2021
    “…This review is reported in line with the Preferred Reporting Items for a Systematic Review and Meta-analysis of Diagnostic Test Accuracy Studies guidelines. …”
    Get full text
    Journal Article
  13. 1393
  14. 1394
  15. 1395

    Development of reconstructed intestinal micronucleus cytome (RICyt) assay in 3D human gut model for genotoxicity assessment of orally ingested substances by Lim, Hui Kheng, Hughes, Christopher Owen, Lim, Michelle Jing Sin, Li, Jia'En Jasmine, Rakshit, Moumita, Yeo, Calvin, Chng, Kern Rei, Li, Angela, Chan, Joanne Sheot Harn, Ng, Kee Woei, Leavesley, David Ian, Smith, Benjamin Paul Chapman

    Published 2022
    “…Micronucleus assays typically utilise homogenous in vitro cell lines which poorly recapitulate the physiology, biochemistry and genomic events in the gut, the site of first contact for ingested materials. …”
    Get full text
    Journal Article
  16. 1396

    Signalling inhibition by ponatinib disrupts productive alternative lengthening of telomeres (ALT) by Kusuma, Frances Karla, Prabhu, Aishvaryaa, Tieo, Galen, Syed Moiz Ahmed, Dakle, Pushkar, Yong, Wai Khang, Pathak, Elina, Madan, Vikas, Jiang, Yan Yi, Tam, Wai Leong, Kappei, Dennis, Dröge, Peter, Koeffler, H. Phillip, Jeitany, Maya

    Published 2023
    “…By performing anti-cancer compound library screen on isogenic cell lines and using extrachromosomal telomeric C-circles, as a bona fide marker of ALT activity, we identify a receptor tyrosine kinase inhibitor ponatinib that deregulates ALT mechanisms, induces telomeric dysfunction, reduced ALT-associated telomere synthesis, and targets, in vivo, ALT-positive cells. …”
    Get full text
    Journal Article
  17. 1397
  18. 1398
  19. 1399
  20. 1400